Status:
COMPLETED
Efficacy and Mechanism of High-Dose Vitamin D Supplementation in Pediatric OAB-Dry: A Randomized Clinical Trial Integrating Urinary Myelin Basic Protein as a Theranostic Biomarker
Lead Sponsor:
Xing Liu
Collaborating Sponsors:
Beijing Children's Hospital
Shanghai Children's Hospital
Conditions:
Overactive Bladder
Pediatric Disorder
Eligibility:
All Genders
5-18 years
Phase:
NA
Brief Summary
The aim of this study is to give children with dry OAB: (1) Standard behavioral therapy combined with classical anticholinergic drugs (Solinaxine), or (2) standard behavioral therapy combined with sho...
Eligibility Criteria
Inclusion
- Children older than 5 years who were admitted to the Department of Urology, Children's Hospital Affiliated to Chongqing Medical University and diagnosed with dry OAB.
- The results of our laboratory indicated that the serum vitamin D level was lower than 35ng/mL.
- The child (guardian) has been informed of the nature of the study, understands the provisions in the protocol, is able to guarantee compliance, and signs the informed consent.
Exclusion
- Patients with other urinary system malformations or serious diseases (such as hypospadias, cryptorchidism, posterior urethral valvular disease, vesicoureteral reflux, neurogenic bladder, urinary system tumors, urinary calculi, bladder and urethral injuries, etc.);
- complicated with neurological diseases (such as epilepsy, spinal cord injury, spinal cord dysplasia, tethered cord syndrome, multiple sclerosis, autism spectrum disorder, etc.);
- Patients with severe heart disease, abnormal liver and kidney function, lung disease, bone malformation, severe digestive tract disease, and genetic metabolic disease;
- History of gastrointestinal surgery and urinary system surgery;
- Dry stool, long-term constipation;
- are taking anticonvulsant and antiepileptic drugs, hormones, antituberculosis drugs;
- Previous history of hypercalcemia, hyperphosphatemia with renal rickets;
- History of unexplained hematuria and urinary tract infection in the past 1 year;
- Have a history of allergy or allergic reaction to vitamin D preparations;
- Participating in another clinical study at the time of visit or during the follow-up of another clinical study;
- Those who did not want to participate in the study or had poor follow-up compliance
Key Trial Info
Start Date :
December 28 2024
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 3 2025
Estimated Enrollment :
180 Patients enrolled
Trial Details
Trial ID
NCT06489951
Start Date
December 28 2024
End Date
July 3 2025
Last Update
November 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China, 400000